These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 28615710)
1. An alternative conformation of ERβ bound to estradiol reveals H12 in a stable antagonist position. Souza PCT; Textor LC; Melo DC; Nascimento AS; Skaf MS; Polikarpov I Sci Rep; 2017 Jun; 7(1):3509. PubMed ID: 28615710 [TBL] [Abstract][Full Text] [Related]
2. Structure activity relationships and differential interactions and functional activity of various equine estrogens mediated via estrogen receptors (ERs) ERalpha and ERbeta. Bhavnani BR; Tam SP; Lu X Endocrinology; 2008 Oct; 149(10):4857-70. PubMed ID: 18599548 [TBL] [Abstract][Full Text] [Related]
3. Binding of estrogen receptor beta to estrogen response element in situ is independent of estradiol and impaired by its amino terminus. Huang J; Li X; Maguire CA; Hilf R; Bambara RA; Muyan M Mol Endocrinol; 2005 Nov; 19(11):2696-712. PubMed ID: 15976006 [TBL] [Abstract][Full Text] [Related]
4. Unique ligand binding patterns between estrogen receptor alpha and beta revealed by hydrogen-deuterium exchange. Dai SY; Burris TP; Dodge JA; Montrose-Rafizadeh C; Wang Y; Pascal BD; Chalmers MJ; Griffin PR Biochemistry; 2009 Oct; 48(40):9668-76. PubMed ID: 19739677 [TBL] [Abstract][Full Text] [Related]
5. Structural characterization of the binding interactions of various endogenous estrogen metabolites with human estrogen receptor α and β subtypes: a molecular modeling study. Wang P; McInnes C; Zhu BT PLoS One; 2013; 8(9):e74615. PubMed ID: 24098659 [TBL] [Abstract][Full Text] [Related]
6. Transcriptional activity of estrogen receptors ERalpha and ERbeta in the EtC.1 cerebellar granule cell line. Gottfried-Blackmore A; Croft G; McEwen BS; Bulloch K Brain Res; 2007 Dec; 1186():41-7. PubMed ID: 18021758 [TBL] [Abstract][Full Text] [Related]
7. 3D models of human ERα and ERβ complexed with 5-androsten-3β,17β-diol. Baker ME; Uh KY; Chandsawangbhuwana C Steroids; 2012 Oct; 77(12):1192-7. PubMed ID: 22921477 [TBL] [Abstract][Full Text] [Related]
8. Conformational dynamics of the estrogen receptor alpha: molecular dynamics simulations of the influence of binding site structure on protein dynamics. Celik L; Lund JD; Schiøtt B Biochemistry; 2007 Feb; 46(7):1743-58. PubMed ID: 17249692 [TBL] [Abstract][Full Text] [Related]
9. Ligand unbinding from the estrogen receptor: a computational study of pathways and ligand specificity. Burendahl S; Danciulescu C; Nilsson L Proteins; 2009 Dec; 77(4):842-56. PubMed ID: 19626711 [TBL] [Abstract][Full Text] [Related]
10. Simulations reveal increased fluctuations in estrogen receptor-alpha conformation upon antagonist binding. Ng HL J Mol Graph Model; 2016 Sep; 69():72-7. PubMed ID: 27580485 [TBL] [Abstract][Full Text] [Related]
11. Oestrogen receptors pathways to oestrogen responsive elements: the transactivation function-1 acts as the keystone of oestrogen receptor (ER)beta-mediated transcriptional repression of ERalpha. Gougelet A; Mueller SO; Korach KS; Renoir JM J Steroid Biochem Mol Biol; 2007 May; 104(3-5):110-22. PubMed ID: 17478088 [TBL] [Abstract][Full Text] [Related]
13. Effects of estradiol and 4-hydroxytamoxifen on the conformation, thermal stability, and DNA recognition of estrogen receptor beta. Vijayanathan V; Greenfield NJ; Thomas TJ; Ivanova MM; Tyulmenkov VV; Klinge CM; Gallo MA; Thomas T Biochem Cell Biol; 2007 Feb; 85(1):1-10. PubMed ID: 17464340 [TBL] [Abstract][Full Text] [Related]
14. Identification of coregulators influenced by estrogen receptor subtype specific binding of the ER antagonists 4-hydroxytamoxifen and fulvestrant. Evers NM; Wang S; van den Berg JH; Houtman R; Melchers D; de Haan LH; Ederveen AG; Groten JP; Rietjens IM Chem Biol Interact; 2014 Sep; 220():222-30. PubMed ID: 25014417 [TBL] [Abstract][Full Text] [Related]
15. Use of binding energy in comparative molecular field analysis of isoform selective estrogen receptor ligands. Wolohan P; Reichert DE J Mol Graph Model; 2004 Sep; 23(1):23-38. PubMed ID: 15331051 [TBL] [Abstract][Full Text] [Related]
16. Interaction of tetrahydrocrysene ketone with estrogen receptors alpha and beta indicates conformational differences in the receptor subtypes. Tyulmenkov VV; Klinge CM Arch Biochem Biophys; 2000 Sep; 381(1):135-42. PubMed ID: 11019829 [TBL] [Abstract][Full Text] [Related]
17. 3D models of human ERα and ERβ complexed with coumestrol. Chandsawangbhuwana C; Baker ME Steroids; 2014 Feb; 80():37-43. PubMed ID: 24315835 [TBL] [Abstract][Full Text] [Related]
18. Structural insights into the mode of action of a pure antiestrogen. Pike AC; Brzozowski AM; Walton J; Hubbard RE; Thorsell AG; Li YL; Gustafsson JA; Carlquist M Structure; 2001 Feb; 9(2):145-53. PubMed ID: 11250199 [TBL] [Abstract][Full Text] [Related]
19. Structure of the ligand-binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonist. Pike AC; Brzozowski AM; Hubbard RE; Bonn T; Thorsell AG; Engström O; Ljunggren J; Gustafsson JA; Carlquist M EMBO J; 1999 Sep; 18(17):4608-18. PubMed ID: 10469641 [TBL] [Abstract][Full Text] [Related]
20. Determination and analysis of agonist and antagonist potential of naturally occurring flavonoids for estrogen receptor (ERα) by various parameters and molecular modelling approach. Puranik NV; Srivastava P; Bhatt G; John Mary DJS; Limaye AM; Sivaraman J Sci Rep; 2019 May; 9(1):7450. PubMed ID: 31092862 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]